High-Dose IV Iron Reduces MI in Patients on Hemodialysis
High-dose versus low-dose intravenous iron reduces myocardial infarctions in patients receiving maintenance hemodialysis
Myocardial Infarction
Higher Levels of CML and NOX2 in Brain Microvasculature Post-Myocardial Infarction
Researchers sought to examine the presence of CML and NOX2 proinflammatory factors in the brain microvasculature of patients with myocardial infarction.
Mental Stress Worsens Cardiovascular Outcomes in Coronary Heart Disease
Researchers compared the link between mental stress- or conventional stress-induced ischemia and adverse CV events in patients with coronary heart disease.
USPSTF Draft Recommendation on Aspirin: What Approach Should Clinicians Take?
In an interview, Jeffrey S Berger, MD, shares his thoughts on updated USPSTF guidelines that address risk of major bleeding from aspirin use for primary prevention of CVD.
Benefit of Prolonged DAPT Following PCI Questioned
Attenuated benefits, greater harms estimated for prolonged DAPT following coronary stent procedures in contemporary patient population.
Nonfatal Myocardial Infarction Not a Surrogate for All-Cause, CV Mortality in CAD
Investigators searched PubMed for randomized clinical trials on treating or preventing coronary artery disease to determine whether nonfatal myocardial infarction was a surrogate for all-cause or CV mortality.
No Overall Benefit of Early Anticoagulant Therapy for Ischemic Stroke
In a Cochrane Review update, researchers sought to assess the effectiveness and safety of early anticoagulation for people with acute presumed or confirmed ischemic stroke.
Long-Term Beta-Blocker Use Reduces Recurrent ACS After Myocardial Infarction
Investigators performed a retrospective observational study to determine if long-term use of beta-blockers is associated with risk for recurrent ischemic events or all-cause mortality.
Genotype Testing Effectively Guides Post-PCI P2Y12 Inhibitor Therapy
Patients with ACS who underwent percutaneous coronary intervention benefited from a genotype-guided P2Y12 inhibitor antiplatelet strategy.
Cardiovascular Disease Risk Increased in Young, Black US Adults
Researchers at AHA 2021 presented their findings from a study that compared CVD risk factors and in-hospital outcomes in young, Black US adults a decade apart.
- Loading...
Loading...
Next post in AHA 2021
Loading... 
Loading...